Be Ready for Questions About Molnupiravir to Treat COVID-19
January 2022
You'll hear buzz about molnupiravir, an oral antiviral to treat COVID-19.
Molnupiravir blocks viral replication by incorporating itself into the RNA of SARS-CoV-2...causing viral death.
It's 4 capsules bid for 5 days...and seems well tolerated.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote